Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
The Effects of Breathing With a Positive Expiratory Pressure Device on The Rate of Post-exercise Recovery in Patients With COPD
Most daily activities involve alternating periods of exercise and rest. If recovery is slow
following exercise it means that the next period of activity may be more difficult and the
COPD patients becomes restricted in their daily life. Therefore, the investigators are
interested to study the effectiveness and physiological effects of breathing with a PEP
device during post-exercise period and hypothesize that
1. Post-exercise breathing with PEP device will increase the rate of recovery more than
breathing without PEP device.
2. Post-exercise breathing with PEP device will not create harmful effects on
cardiopulmonary function in COPD patients.
Chronic obstructive pulmonary disease (COPD) was the 4th leading cause of morbidity and
mortality worldwide in 2012 and represents an important public health challenge that is both
preventable and treatable. COPD is characterized by persistent airflow limitation that is
usually progressive and associated with an enhanced chronic inflammatory response in the
airways and the lung to noxious particles or gases.
The pathophysiological hallmark of COPD is an expiratory air flow limitation. During
exercise, increasing ventilatory demands can induce premature airway closure by forced
expiration leading to air trapping and further leading to lung hyperinflation. Dynamic
hyperinflation (DH) during exercise contributes to increased end expiratory lung volume
(EELV), reduces inspiratory capacity (IC), and increases the mechanical load on inspiratory
muscles leading to dyspnea, exercise intolerance, limited physical activity, and thus to a
poor quality of life in COPD patients. In addition, abnormal lung mechanical function during
dynamic hyperinflation leads to increased sensation of dyspnea, which is the disparity
between respiratory drive and the respiratory mechanical response. Abnormal controls of
blood chemicals and of vasculature factors also aggravate the sensation of dyspnea.
The autonomic dysfunction (AD) that occurs in the patients with COPD is evident as an
inability of heart rate to reach an appropriate level during exercise (chronotropic
incompetence; CI). There is also a prolonged heart rate recovery (HRR) at the end of
exercise which may contribute to increase dyspnea sensations and increased mortality rate in
COPD.
Expiratory flow retardation when breathing with a positive expiratory pressure (PEP) device
is the one of various techniques to manage dyspnea in COPD. Most studies using a PEP device
have focused on investigating the effects of PEP to reduce lung hyperinflation, reduce
dyspnea, and increase exercise capacity. Only one study of Martin and Devenport, has
examined the effects of PEP breathing during the recovery periods after exercise and found
that following 6 minutes sub-maximal treadmill walking, 6 breath exhalation against a 10
cmH2O threshold PEP reduced dyspnea and increased HRR. Oxygen pulse saturation (SpO2) was
also increased within 2 minutes although there was no statistical significant between
groups.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|